OncTimes Talk

OncTimes Talk

Por: Oncology Times
OncTimes Talk features a variety of podcast series ranging from breaking news and oncology conference coverage to story round-ups and in-depth interviews with current experts and leaders in oncology.
100 episodios disponibles

Latest episodes of the podcast OncTimes Talk

Mostrando página 4 de 5

Study Finds Durvalumab Improved Progression-Free and Overall Survival in Limited Stage Small Cell Lung Cancer 11/06/2024
German Study Finds New Regimen for Hodgkin Lymphoma More Effective, Less Toxic 11/06/2024
Kinase Inhibitor Delivers Synthetic Lethality to Enhance Radiotherapy in Glioblastoma 29/05/2024
mRNA Vaccine + Checkpoint Inhibitor Combo Had Low Toxicity With Evidence of Efficacy in Advanced NSCLC 29/05/2024
Earliest Detection of Cancer by Artificial Intelligence Analysis of Circulating Cell-Free DNA Fragmentomes 29/05/2024
Clinical Study Shows Selective PARP 1 Inhibitor More Effective, Less Toxic 15/05/2024
Exercise Deters Prostate Cancer Death & Progression 15/05/2024
Bispecific Dual Checkpoint Blockade Extends Life & Slows Progression in Gastric & GE Junction Cancers 15/05/2024
Bispecific T-cell Engager Antibody Brings Deep, Durable Remissions in R/R Multiple Myeloma 02/05/2024
Exosome-Based Liquid Biopsy Promises Very Early Pancreatic Cancer Detection 02/05/2024
Polyepitopic Personalized Vaccine Brought Durable Immune Responses & Clinical Benefit in Resected Head & Neck Cancers 02/05/2024
Mesh-Supported Prepectoral Method of Breast Reconstruction After Breast Cancer Surgery 26/04/2024
Radiotherapy Boost Protects Young Patients With Early Breast Cancer, High Dose Boost Not Needed 26/04/2024
Breast-Conserving Therapy Effective for Ductal Carcinoma in Situ, But Questions Remain 24/04/2024
Three-Node Breast Cancer Spread: Most Patients Can Safely Avoid Axillary Dissection 24/04/2024
Preoperative Partial Breast Irradiation: Marked Benefit in Low-Risk Breast Cancer 12/04/2024
Adjuvant Atezolizumab: No Survival Benefit in Triple-Negative Breast Cancer 11/04/2024
Artificial Intelligence Tool Predicts Postoperative Radiotherapy Lymphedema 11/04/2024
Neoadjuvant Pembrolizumab Improves High-Risk Early Breast Cancer Outcomes 11/04/2024
Gene Test Shows Which Triple-Negative Breast Cancers Do Not Need Pre-Op Pembrolizumab 27/03/2024
« Primera ‹ Anterior 1 2 3 4 5 Siguiente › Última »
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA